NitroMed, Inc.

NitroMed, Inc.

NitroMed, Inc. company has developed a technique to enhance nitric oxide and add it to drugs to improve their efficiency. Nitric oxide is formed in the body and plays a role in relaxing blood vessels, making it harder for blood platelets to stick to blood vessel walls, and thereby reducing the obstructions that lead to stroke. Its sole product, BiDil, has FDA approval and is specifically indicated for heart disease in self-identified African-Americans, a group that suffers from the disease at a higher rate than other ethnicities. NitroMed was acquired by health care investment group Deerfield Capital Management in 2009.

Contact Details

Office Address

NitroMed, Inc.
6000 Fairview Road, Suite 610
Charlotte, NC, USA 28210
Phone: (704) 941-2020
Fax: (704) 941-2021

Executives

President, CEO, and Director, and Interim CFO

Kenneth M. (Ken) Bate

VP Corporate Affairs

Jane A. Kramer

Business Reviews for NitroMed, Inc.

Related Companies